In endometrial cancer cells, miRNA302 inhibits cell proliferation and migration, induces apoptosis, attenuates invasiveness by inhibiting cyclin D1 and CDK1, and arrests the cell cycle in the G2/M phase. Here, CCND1 is linked to endometrial cancer.